TRIB3 Interacts with STAT3 to Promote Cancer Angiogenesis

Abstract

Objective

Vascular endothelial growth factor A (VEGFA) is a key regulator of angiogenesis, which is a hallmark of cancer that promotes cancer growth and metastasis. It is of great significance to find new intervention targets and related regulatory mechanisms of VEGFA related angiogenesis for the treatment of tumors. This study focuses on the role of tribbles pseudokinase 3 (TRIB3)/signal transducer and activator of transcription 3 (STAT3)/VEGFA signaling axis in colon cancer angiogenesis.

Methods

This study investigated the expression level of TRIB3 in colon cancer through database analysis and tissue microarray analysis. The effect of TRIB3 on proliferation, migration and tube formation ability of human umbilical vein endothelial cells (HUVECs) was further confirmed by CCK8 assay, scratch-wound assay/migration assay and tube formation assay respectively. The regulatory relationship of TRIB3/VEGFA signaling axis was identified by qPCR and Western blotting, which was further confirmed through animal experiments, and the specific regulatory mechanism was explored by immunoprecipitation (IP) and chromatin immunoprecipitation (ChIP) with colon cancer cell lines.

Results

TRIB3 was increased in colon cancer tissues compared to normal tissues, and elevated TRIB3 expression indicated a poor prognosis in colon cancer patients. Moreover, it was found that silencing TRIB3 could inhibit cancer angiogenesis, whereas overexpressing TRIB3 promoted cancer angiogenesis in vitro and in vivo. Mechanistically, TRIB3 physically interacted with STAT3 and enhanced STAT3-mediated transcriptional activity. Furthermore, the function of TRIB3 in cancer angiogenesis was through cooperating with STAT3 to increase the VEGFA expression.

Conclusion

Our study provides insights into cancer angiogenesis and offers a potential therapeutic strategy for TRIB3-overexpressed cancer.

Keywords

tribbles pseudo-kinase 3 / signal transducer and activator of transcription 3 / vascular endothelial growth factor / cancer / angiogenesis

References

[1] HanahanD, WeinbergRA. Hallmarks of cancer: the next generation. Cell, 2011, 144(5): 646-674

[2] SieZL, LiRY, SampurnaBP, et al.. WNK1 Kinase Stimulates Angiogenesis to Promote Tumor Growth and Metastasis. Cancers (Basel), 2020, 12(3): 575

[3] KieranMW, KalluriR, ChoYJ. The VEGF pathway in cancer and disease: responses, resistance, and the path forward. Cold Spring Harb Perspect Med, 2012, 2(12): a006593

[4] JaysonGC, KerbelR, EllisLM, et al.. Antiangiogenic therapy in oncology: current status and future directions. Lancet, 2016, 388(10043): 518-529

[5] ApteRS, ChenDS, FerraraN. VEGF in Signaling and Disease: Beyond Discovery and Development. Cell, 2019, 176(6): 1248-1264

[6] Ballmer-HoferK. Vascular Endothelial Growth Factor, from Basic Research to Clinical Applications. Int J Mol Sci, 2018, 19(12): 3750

[7] HuF, SunX, LiG, et al.. Inhibition of SIRT2 limits tumour angiogenesis via inactivation of the STAT3/VEGFA signalling pathway. Cell Death Dis, 2018, 10(1): 9

[8] ZhaoJ, DuP, CuiP, et al.. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer. Oncogene, 2018, 37(30): 4094-4109

[9] NiuG, WrightKL, HuangM, et al.. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene, 2002, 21(13): 2000-2008

[10] WeiLH, KuoML, ChenCA, et al.. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene, 2003, 22(10): 1517-1527

[11] LeeE, FertigEJ, JinK, et al.. Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis. Nat Commun, 2014, 5: 4715

[12] LiuJ, ZhangW, ChuangGC, et al.. Role of TRIB3 in regulation of insulin sensitivity and nutrient metabolism during short-term fasting and nutrient excess. Am J Physiol Endocrinol Metab, 2012, 303(7): E908-916

[13] EyersPA, KeeshanK, KannanN. Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease. Trends Cell Biol, 2017, 27(4): 284-298

[14] HuaF, LiK, YuJJ, et al.. The TRIB3-SQSTM1 interaction mediates metabolic stress-promoted tumorigenesis and progression via suppressing autophagic and proteasomal degradation. Autophagy, 2015, 11(10): 1929-1931

[15] HuaF, ShangS, YangYW, et al.. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Gastroenterology, 2019, 156(3): 708-721.e15

[16] SuJ, YanY, QuJ, et al.. Emodin induces apoptosis of lung cancer cells through ER stress and the TRIB3/NF-κB pathway. Oncol Rep, 2017, 37(3): 1565-1572

[17] MakinoS, TakahashiH, OkuzakiD, et al.. DCLK1 integrates induction of TRIB3, EMT, drug resistance and poor prognosis in colorectal cancer. Carcinogenesis, 2020, 41(3): 394-396

[18] YuJM, SunW, WangZH, et al.. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription. Nat Commun, 2019, 10(1): 5720

[19] HongB, ZhouJ, MaK, et al.. TRIB3 Promotes the Proliferation and Invasion of Renal Cell Carcinoma Cells via Activating MAPK Signaling Pathway. Int J Biol Sci, 2019, 15(3): 587-597

[20] LiK, WangF, CaoWB, et al.. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence. Cancer Cell, 2017, 31(5): 697-710.e7

[21] LiK, ZhangTT, WangF, et al.. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression. Oncogene, 2018, 37(22): 2967-2981

[22] SakuraiT, KudoM. Signaling pathways governing tumor angiogenesis. Oncology, 2011, 81(Suppl 1): 24-29

[23] SongIS, WangAG, YoonSY, et al.. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer. Exp Mol Med, 2009, 41(1): 51-58

[24] SoggiaA, RamondC, AkiyamaH, et al.. von Hippel-Lindau gene disruption in mouse pancreatic progenitors and its consequences on endocrine differentiation in vivo: importance of HIF1-α and VEGF-A upregulation. Diabetologia, 2014, 57(11): 2348-2356

[25] ZhaoC, PopelAS. Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer. PLoS Comput Biol, 2015, 11(11): e1004612

[26] JungJE, LeeHG, ChoIH, et al.. STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB J, 2005, 19(10): 1296-1298

[27] OhokaN, YoshiiS, HattoriT, et al.. TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J, 2005, 24(6): 1243-1255

[28] TakahashiY, OhokaN, HayashiH, et al.. TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activity. J Lipid Res, 2008, 49(4): 880-892

[29] HouZ, GuoK, SunX, et al.. TRIB2 functions as novel oncogene in colorectal cancer by blocking cellular senescence through AP4/p21 signaling. Mol Cancer, 2018, 17(1): 172

[30] LinJ, ZhangW, NiuLT, et al.. TRIB3 Stabilizes High TWIST1 Expression to Promote Rapid APL Progression and ATRA Resistance. Clin Cancer Res, 2019, 25(20): 6228-6242